ACP-ASIM Disappointed at Supreme Court Decision Preventing FDA Regulation of Tobacco
College Calls on Congress to Authorize Meaningful FDA Tobacco Regulation
(WASHINGTON): The American College of Physician - American Society of Internal Medicine (ACP-ASIM) issued a statement today expressing deep disappointment at the Supreme Court's ruling that the U.S. Food and Drug Administration (FDA) does not have jurisdiction to regulate tobacco products or cigarette marketing practices under current law.
"Cigarettes and other tobacco products represent a major health threat to the American public," said ACP-ASIM President Whitney Addington, MD, FACP. "In light of the Supreme Court's action, Congress needs to respond by immediately giving the FDA the authority to regulate this dangerous substance."
Dr. Addington cited legislation drafted by Sen. Bill Frist (R-TN) and included in Sen. John McCain's (R-AZ) tobacco control legislation debated by the United Senate in 1998 as a good model for giving FDA the authority to regulate tobacco. If Congress had passed this bill in 1998, he pointed out, the FDA would already have the authority to implement a tobacco regulation program.
"We must be particularly vigilant so that another generation of children does not become addicted to tobacco," said Dr. Addington. "Strong regulations limiting juvenile access to tobacco products, as well as tight controls on tobacco company marketing practices, are a must."
ACP-ASIM is the nation's largest medical specialty organization and the second largest physician group. Membership comprises more than 115,000 internal medicine physicians and medical students. Internists are the major providers of medical care to adults in America.
Jack E. Pope, ACP-ASIM Washington Office, (202) 261-4556
Page updated: 11-03-03